Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The Value Line Select Growth Fund focused on high-quality large- and mid-cap companies with predictable earnings and consistent growth during Q1 2026, delivering a return of -7.74% and outperforming its benchmark category amidst macro uncertainty and market volatility driven by geopolitical tensions.
Full Quick Take
The Value Line Select Growth Fund focused on high-quality large- and mid-cap companies with predictable earnings and consistent growth during Q1 2026, delivering a return of -7.74% and outperforming its benchmark category amidst macro uncertainty and market volatility driven by geopolitical tensions.
The Hennessy Technology Fund is an actively managed mutual fund focusing on 60 equally weighted technology stocks selected via strict financial and valuation screens.
Full Quick Take
The Hennessy Technology Fund is an actively managed mutual fund focusing on 60 equally weighted technology stocks selected via strict financial and valuation screens.
The Oakmark Fund underperformed the S&P 500 in Q3 2025 due to an IT underweight, but continues to deploy capital into high-quality value names like Targa Resources and Union Pacific.
Full Quick Take
The Oakmark Fund underperformed the S&P 500 in Q3 2025 due to an IT underweight, but continues to deploy capital into high-quality value names like Targa Resources and Union Pacific.
The fund posted minor gains in Q3 2025 but lagged the benchmark due to currency and political headwinds, while actively shifting away from slower-growth healthcare names to align with long-term AI and supply chain recovery themes.
Full Quick Take
The fund posted minor gains in Q3 2025 but lagged the benchmark due to currency and political headwinds, while actively shifting away from slower-growth healthcare names to align with long-term AI and supply chain recovery themes.
